Show notes
Please join Dr Xenophon Kassianides, Prof Derek Connolly and Dr Rani Khatib for a comprehensive recap of the progress in CVRM medicine during 2025: Outlining antiplatelet drugs and beta blockers post ACS Discussing the ESC guidelines update on cholesterol management, the importance of a full lipid profile and the evidence for combination therapy The evolving market of antihypertensive drugs The obesity pandemic, how GLP-1’s support weight loss, highlighting the need for concurrent proactive h...

